10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that the European Unified Patent Court ("UPC") issued a preliminary injunction against NanoString Technologies, Inc. (Nasdaq: NSTG) for infringing European Patent 4 108 782 B1 ("the EP 782 patent," docket No 459746/2023). The preliminary injunction, issued by a panel of four judges with both legal and technical expertise, prevents NanoString from selling or providing services using its CosMx Spatial Mo
NanoString Will Immediately Appeal Preliminary Injunction Temporarily Blocking NanoString’s Ability to Market and Sell CosMx Spatial Molecular Imager Products for RNA Detection within UPC Member.
10x Genomics (TXG) Wins Injunction From Unified Patent Court Banning Sales of NanoString s (NSTG) CosMx Products in Europe streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
NanoString stock falls after prelim injunction in Germany in dispute with 10x Genomics seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.